The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more ...

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...

Research in idiopathic pulmonary fibrosis is progressing rapidly, with the goal of delivering more treatments to patients at ...

The FDA has accepted for review the BLA for mepolizumab as an add-on maintenance treatment for eosinophilic COPD.

An injection of a drug already on the market, Benralizamab, promises to be the next revolution in the treatment of asthma ...

GSK (GSK) announced the US Food and Drug Administration, FDA, has accepted for review, data from the MATINEE study to support the regulatory ...

The company said the unanticipated events of pericardial effusion--when fluid builds up in the space around the heart--came in the Phase 2 clinical trial of 3 milligrams per kilogram and 4.6 mg/kg ...

I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I'm dealing with the effects of it ...

The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into ...